Date

Sep 29 2021
Expired!

Hit finding against acute and chronic inflammation

Content

Can ultra-High-Throughput Screening be exploited to identify novel compounds against protein multimerization?

Watch this webinar on 28 September 16.00 hrs. (CET) and learn about:

  • Development, optimization and miniaturization of screening assay cascade
  • ultra-Hgh-Throughput Screening of large compounds
  • Hit validation and triaging

​​​​​​​The innate immune system is crucial for initiation and amplification of inflammatory responses and tissue destruction in many diseases. Calcium binding proteins plays a major role in Immune-Mediated Inflammatory Diseases, some of which are currently used as diagnostic biomarkers in a subset of inflammatory diseases. Several pro-inflammatory functions have been ascribed to calcium binding proteins and as such, making them solid targets for small-molecule therapeutics.

Register here.

Presentation by:
Dr. Saman Honarnejad - Director Drug Discovery, Pivot Park Screening Centre

Duration
Presentation: 45 minutes (16:00 hrs. CET)
You can view this webinar from your computer, tablet or mobile phone.

​About the presenter:
Dr. Saman Honarnejad is a biotechnologist with over a decade of experience in High Throughput Biology. At Pivot Park Screening Centre (PPSC) in Oss, the Netherlands, he is involved in cellular and biochemical assay development, ultra-High Throughput screening (uHTS) and Hit-to-Lead (H2L) biological compound profiling within a wide range of commercial, academic and public-private partnership projects including the European Lead Factory (ELF).

Prior to joining PPSC in 2017, he was active in high-content compound profiling method development at Max-Planck Institute (Germany), Harvard Medical School (United States) and Heidelberg University (Germany) and further optimized microarray-based cDNA/RNAi functional screening assays at the European Molecular Biology Laboratory (EMBL).

Info

Organizer

Pivot Park
Email
info@pivotpark.com

Time

16:00 - 17:00

Hourly Schedule

Programme

16:00
Presentation
Speakers:
Dr. Saman Honarnejad
Dr. Saman Honarnejad
Dr. Saman Honarnejad
Director Drug Discovery, Pivot Park Screening Centre
Dr. Saman Honarnejad is a biotechnologist with over a decade of experience in High Throughput Biology. At Pivot Park Screening Centre (PPSC) in Oss, the Netherlands, he is involved in cellular and biochemical assay development, ultra-High Throughput screening (uHTS) and Hit-to-Lead (H2L) biological compound profiling within a wide range of commercial, academic and public-private partnership projects including the European Lead Factory (ELF).

Pivot Park Captains' Dinner

10 years ago, Pivot Park opened its doors to the world. Thanks to your commitment, support and confidence, we have been able to grow it into the successful and innovative biopharmaceutical campus it is today.

Now it’s time to celebrate!

We are therefore delighted to invite you – along with all your fellow CEOs at Pivot Park – to a special night out featuring inspiring art, a wonderful dinner and lots of opportunities to network and exchange ideas.

Erwin Wurm | Am I a House?

For the first time, the artist shows a cross-section of his work, from Narrow Furniture to One Minute Sculptures, within the walls of a historic building. Villa Constance, a former home that today houses Museum Jan Cunen, is not only a location but also part of the conversation. Because what exactly is a house?

#100YEARSPHARMAFUTURE

The development of medicines in Oss began one hundred years ago. It was then that the foundations were laid for what would become a flourishing pharmaceutical sector in the Netherlands, leading to groundbreaking discoveries such as insulin and the anti-conception pill.

Today, the entire chain is still represented in Oss, from early-stage research to the commercial scale production of medicines. Working in Oss, we focus on the health of people all over the world. Employees at dozens of companies large and small put their heart and soul into new medicines, products and services that will improve lives worldwide. Together, our strength lies in our combination of broad knowledge about the development of medicines and a thorough understanding of the requirements of high-quality production.

This shared past and common values stimulate strong bonds among everyone who works in pharmaceuticals in Oss. We build on qualities, expertise and networks that go back decades. And with a wide variety of pharmaceutical companies, suppliers and scientific institutions all located nearby, we offer an attractive business climate and an excellent basis for international collaboration.

We are proud to work together to create a better and healthier future for all, a collaboration that in turn fuels growing employment: today, most pharmaceutical jobs in the Netherlands are in Oss. Here we connect talent and companies and stimulate entrepreneurship, while our expert employees are our most important asset. Their drive ensures that Oss has an influence on health all over the world.

Pharma in Oss offers endless opportunities to startups and talent in a city and region that is a joy to live and work in. We are committed to collaboration and sustainable and successful entrepreneurship. Oss’s pharmaceutical companies are intrinsically competitive while also being committed to quality and safety. This, plus their focus on new health solutions and contemporary technology, makes us a leader in our pursuit of a better life for people worldwide.